Skip to main content

Articles

Page 9 of 12

  1. Public-private partnership (PPP) initiatives are extending around the world, especially in Europe, as an innovation to traditional public health systems, with the intention of making them more efficient.

    Authors: Maria Caballer-Tarazona and David Vivas-Consuelo
    Citation: Health Economics Review 2016 6:17

    The Erratum to this article has been published in Health Economics Review 2016 6:20

  2. The perception of the health sector from an economic policy point of view is changing. In the past, health expenditure was mostly seen as a “cost” item, probably because many medical treatments are covered by ...

    Authors: Dennis A. Ostwald and David Klingenberger
    Citation: Health Economics Review 2016 6:11
  3. The role of Home Care (HC) services for the elderly will be increasingly important in meeting populations’ future needs for care. HC services include Home Health Care (HHC) and Homemaking/Personal Support (HMP...

    Authors: Gustavo Mery, Walter P. Wodchis and Audrey Laporte
    Citation: Health Economics Review 2016 6:8
  4. For optimal solutions in health care, decision makers inevitably must evaluate trade-offs, which call for multi-attribute valuation methods. Researchers have proposed using best-worst scaling (BWS) methods whi...

    Authors: Axel C. Mühlbacher, Peter Zweifel, Anika Kaczynski and F. Reed Johnson
    Citation: Health Economics Review 2016 6:5
  5. The association of social capital and alcohol consumption is one of the most robust empirical findings in health economics of the past decade. However, the direction of the relationship between the two is heav...

    Authors: Abdu Kedir Seid
    Citation: Health Economics Review 2016 6:3
  6. Best-worst scaling (BWS), also known as maximum-difference scaling, is a multiattribute approach to measuring preferences. BWS aims at the analysis of preferences regarding a set of attributes, their levels or...

    Authors: Axel C. Mühlbacher, Anika Kaczynski, Peter Zweifel and F. Reed Johnson
    Citation: Health Economics Review 2016 6:2
  7. The costs and treatment patterns of attention deficit hyperactivity disorder (ADHD) are subjects of health services research in Germany and worldwide. Previous publications focused mainly on prevalent patients...

    Authors: Mike Klora, Jan Zeidler, Roland Linder, Frank Verheyen and J.-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2015 5:40
  8. The introduction in 2010 of the Freedom of Choice Act represents one of the most far-reaching reforms of the Swedish health system. While it is mandatory for the regional counties to introduce choice plans for...

    Authors: Björn Ekman and Jens Wilkens
    Citation: Health Economics Review 2015 5:39
  9. In this paper we examine the effect of dollar stores on children’s Body Mass Index (BMI). We use a dataset compiled by the Arkansas Center for Health Improvement that reflects a BMI screening program for publi...

    Authors: Andreas C. Drichoutis, Rodolfo M. Nayga Jr., Heather L. Rouse and Michael R. Thomsen
    Citation: Health Economics Review 2015 5:37
  10. This article examines a model of competition between two types of health insurer: Health Maintenance Organizations (HMOs) and nonintegrated insurers. HMOs vertically integrate health care providers and pay the...

    Authors: Edmond Baranes and David Bardey
    Citation: Health Economics Review 2015 5:36
  11. An increasing number of primary prevention programs aimed at promoting physical exercise in children and adolescents are being piloted. As resources are limited, it is important to ascertain the costs and bene...

    Authors: Katharina Korber
    Citation: Health Economics Review 2015 5:35
  12. Malnutrition is a prevalent public health concern in Ghana. While studies have identified factors that influence child malnutrition and related inequalities in Ghana, very little efforts have been made to deco...

    Authors: Jacob Novignon, Emmanuel Aboagye, Otuo Serebour Agyemang and Genevieve Aryeetey
    Citation: Health Economics Review 2015 5:34
  13. The Escala Study evidenced that the administration of glatiramer acetate for relapsing-remitting multiple sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether su...

    Authors: Rainel Sánchez-de la Rosa, Laura García-Bujalance and José Meca-Lallana
    Citation: Health Economics Review 2015 5:30
  14. The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not co...

    Authors: Ansgar Lange, Anne Prenzler, Oliver Bachmann, Roland Linder, Sarah Neubauer, Jan Zeidler, Michael P. Manns and J.-Matthias von der Schulenburg
    Citation: Health Economics Review 2015 5:29
  15. This study aims to systematically evaluate available evidence regarding direct medical costs of treating cardiovascular (CV) events in Germany after 2003 on an individual patient basis and from a payer perspec...

    Authors: Tamara Schmid
    Citation: Health Economics Review 2015 5:27

    The Erratum to this article has been published in Health Economics Review 2016 6:1

  16. Low-income countries are plagued by a high burden of preventable and curable disease as well as unmet need for healthcare, but detailed microeconomic evidence on the relationship between supply-side factors an...

    Authors: Laura Anselmi, Mylène Lagarde and Kara Hanson
    Citation: Health Economics Review 2015 5:26
  17. Despite substantial public health efforts to increase HIV testing, testing rates have plateaued in many countries and rates of repeat testing for those with ongoing risk are low. To inform policies aimed at in...

    Authors: Jan Ostermann, Derek S. Brown, Axel Mühlbacher, Bernard Njau and Nathan Thielman
    Citation: Health Economics Review 2015 5:24
  18. HPV infections can cause substantial burden in females and males as it is associated with several genital cancers, in addition to genital warts. Traditional economic evaluations often focus on quantifying cost...

    Authors: Nikolaos Kotsopoulos, Mark P Connolly and Vanessa Remy
    Citation: Health Economics Review 2015 5:23
  19. Recent studies provide evidence of improved clinical benefits associated with cardiac resynchronization therapy (CRT) optimization. Our analysis explores the cost-effectiveness of systematically optimized (SO,...

    Authors: Kurt Banz, Peter Paul Delnoy and Jean Renaud Billuart
    Citation: Health Economics Review 2015 5:19
  20. Health authorities are constantly searching for new ways to stabilise health expenditures. To explore this issue, we compared the costs generated by different types of medical practice in French general medici...

    Authors: Aurélie Colas, Karine Danno, Cynthia Tabar, Jenifer Ehreth and Gérard Duru
    Citation: Health Economics Review 2015 5:18
  21. Apixaban, a novel oral anticoagulant which has been approved for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation, reduces both ischemic and haemorrhagic stroke and produces f...

    Authors: Mariano Anibal Giorgi, Christian Caroli, Norberto Damian Giglio, Paula Micone, Eleonora Aiello, Cristina Vulcano, Julia Blanco, Bonnie Donato and Joaquin Mould Quevedo
    Citation: Health Economics Review 2015 5:17
  22. In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an inc...

    Authors: Blanca Gros, Antonio Galán, Emilio González-Parra, Jose A Herrero, Maria Echave, Stefan Vegter, Keith Tolley and Itziar Oyagüez
    Citation: Health Economics Review 2015 5:14
  23. Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA) and have less gastrointestinal ...

    Authors: Sherif A Nasef, A. Aziz Shaaban, Joaquin Mould-Quevedo and Tarek A Ismail
    Citation: Health Economics Review 2015 5:13
  24. The use of subgroups based on biological-clinical and socio-demographic variables to deal with population heterogeneity is well-established in public policy. The use of subgroups based on preferences is rare, ...

    Authors: Mette Kjer Kaltoft, Robin Turner, Michelle Cunich, Glenn Salkeld, Jesper Bo Nielsen and Jack Dowie
    Citation: Health Economics Review 2015 5:10
  25. This article examines young people's preferences for integrated family planning (FP) and HIV services in rural Malawi. Different hypothetical configurations for outreach services are presented using a Discrete...

    Authors: Christine Michaels-Igbokwe, Mylene Lagarde, John Cairns and Fern Terris-Prestholt
    Citation: Health Economics Review 2015 5:9

Annual Journal Metrics

  • 2022 Citation Impact
    2.4 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.204 - SNIP (Source Normalized Impact per Paper)
    0.836 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    220 days submission to accept (Median)

    2023 Usage 
    566,888 downloads
    483 Altmetric mentions